Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000050092 | SCV000487247 | pathogenic | Cohen syndrome | 2016-10-31 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000050092 | SCV002232982 | pathogenic | Cohen syndrome | 2022-09-23 | criteria provided, single submitter | clinical testing | This variant is present in population databases (rs386834099, gnomAD 0.03%). For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 56679). This premature translational stop signal has been observed in individuals with Cohen syndrome (PMID: 15141358). This sequence change creates a premature translational stop signal (p.Arg1943*) in the VPS13B gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in VPS13B are known to be pathogenic (PMID: 15141358, 16648375, 20461111). |
Juha Muilu Group; Institute for Molecular Medicine Finland |
RCV000050092 | SCV000082501 | probable-pathogenic | Cohen syndrome | no assertion criteria provided | not provided | Converted during submission to Likely pathogenic. |